SNCA and Parkinson disease: This differential PET signal observed within the synucleinopathy spectrum could be explained by either the higher levels of a-synuclein pathology present in MSA versus PD or LBD [25], or by the well-described differences in the conformation of the a-synuclein aggregates in these diseases [12].